PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

NICE recommends cenobamate for treatment of adult epilepsy patients in UK

NICE has issued a positive recommendation for Arvelle Therapeutics’ cenobamate (Ontozry), for the treatment of focal-onset seizures in adults with uncontrolled epile...
Continue Reading →
News

ACG ‘Makes it Better’

World’s largest integrated supplier of solid dosage pharmaceutical and nutraceutical products rebrands, flagging its commitment to making the world healthier, togeth...
Continue Reading →
News

Winners of the 2021 CPhI Pharma Awards have now been announced

The 2021 CPhI Pharma Award winners by category: Excellence in Pharma: CEO of the Year - Lynne Ann du Toit, Eurolab Excellence in Pharma: Packaging & ...
Continue Reading →
News

Pharma confidence surges as CPhI Worldwide 2021 opens

CPhI Pharma Index reaches record high as pharma confidence in growth rises in all markets CPhI Worldwide – hosted in-person at Fiera Milano, Italy (9-11 Nove...
Continue Reading →
News

Positive results for GSK’s anaemia drug daprodustat

GlaxoSmithKline (GSK) has revealed positive data for its investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) daprodustat in patients...
Continue Reading →
News

Opdivo plus chemo improves event-free survival in NSCLC patients

Bristol Myers Squibb (BMS) has announced that its PD-1 inhibitor Opdivo (nivolumab) plus chemotherapy improved event-free survival in a Phase III trial in patients w...
Continue Reading →
News

AZ announces US fast track designation for IL-5 inhibitor Fasenra

AstraZeneca’s IL-5 inhibitor Fasenra (benralizumab) has received a fast-track designation from the US Food and Drug Administration for the treatment of eosinoph...
Continue Reading →
News

Aenova increases production capacity for solid dosage forms at Tittmoning site to up to 10 billion tablets per year

The investment project to expand tablet manufacturing capacity is nearing completion; routine operations will start in the first quarter of 2022. With the commis...
Continue Reading →
News

Aragen expects to ride wave of US biotech growth in 2022 – influx of discovery capital is surging demand for CDMO services

Company plans wide-ranging investments and expansions to keep pace with demand driven by macro-changes and diversifying client base Aragen Life Sciences (for...
Continue Reading →
News

UK government to cut cost of repeatable HRT prescriptions

The government has promised a cut to the cost of Hormone Replacement Therapy (HRT) prescriptions for women approaching or experiencing symptoms of menopause. A ne...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026